Correction to: Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling

Autor: M. Martín, J. C. de la Torre-Montero, S. López-Tarruella, K. Pinilla, A. Casado, S. Fernandez, Y. Jerez, J. Puente, I. Palomero, R. González del Val, M. del Monte-Millan, T. Massarrah, C. Vila, B. García-Paredes, J. A. García-Sáenz, A. Lluch
Rok vydání: 2018
Předmět:
Zdroj: BREAST CANCER RESEARCH AND TREATMENT
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
ISSN: 0167-6806
Popis: Persistent alopecia (PA) after docetaxel has been recently described. The aim of our study is to establish the incidence and characteristics of PA following adjuvant docetaxel for breast cancer (BC) and to test the ability of scalp cooling in prevention.BC patients receiving adjuvant chemotherapy followed or not by endocrine therapy (and a control group receiving only endocrine therapy) were interviewed in a single institution at 1.5 to 5 years following primary diagnosis searching for PA. A confirmatory prevalence study was later performed in other two institutions. Finally, a prevention study using prophylactic scalp cooling (PSC) with ELASTO-GEL hypothermia caps in patients receiving adjuvant docetaxel was performed.In the initial prevalence study (492 patients), minor forms of PA (grade 1) were recorded with all chemotherapy regimens and aromatase inhibitors. Patients receiving docetaxel regimens at cumulative dose (CD) ≥ 400 mmg/mAdjuvant treatment with docetaxel (CD ≥ 400 mmg/m
Databáze: OpenAIRE
Externí odkaz: